School of Medicine
Showing 111-120 of 136 Results
-
Sharon Sha, MD, MS
Clinical Professor, Adult Neurology
BioDr. Sha is a Clinical Professor of Neurology and Neurological Sciences at Stanford University where she serves as Chief for the Memory Disorders Division and the Stanford Memory Disorders Center, Associate Vice Chair of Clinical Research, Director of the Huntington’s Disease Center of Excellence and Ataxia Clinic, Co-Director of the Lewy Body Disease Association Research Center of Excellence, and Clinical Core Co-Leader of the Stanford Alzheimer's Disease Research Center. Her clinical time is devoted to caring for patients with Alzheimer’s disease and other neurodegenerative disorders and her research is devoted to finding treatments for these cognitive disorders. She also served on the California Governor’s Alzheimer’s Prevention and Preparedness Task Force Chaired by Maria Shriver in 2020. She has been featured in international media and documentaries such as the BBC "How to Stay Young" and the Docuseries "Limitless with Chris Hemsworth".
-
Irina Skylar-Scott
Clinical Assistant Professor, Adult Neurology
BioDr. Skylar-Scott is a board-certified, fellowship-trained cognitive and behavioral neurologist and clinical assistant professor at Stanford University. She is a Diplomate of the American Board of Psychiatry and Neurology as well as the United Council for Neurologic Subspecialties in Behavioral Neurology and Neuropsychiatry.
Her clinical interests include the treatment of cognitive and behavioral impairment due to Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, posterior cortical atrophy, primary progressive aphasia, frontotemporal dementia, vascular dementia, primary age-related tauopathy, and limbic-predominant age-associated TDP-43 encephalopathy, among other disorders of cognition and behavior.
Her research interests include clinical trials for Alzheimer’s disease and how social and intellectual engagement can affect cognition. She has also investigated impaired consciousness in epilepsy and biomarkers for assessing Duchenne muscular dystrophy. Prior to joining Stanford, Dr. Skylar-Scott was a fellow in the Center for Alzheimer’s Research and Treatment (CART) in the Department of Neurology at Harvard Medical School/Brigham and Women’s Hospital. She also completed her undergraduate degree at MIT, her MD at Yale, and her residency at Harvard.
Dr. Skylar-Scott’s work has appeared in Neurology, Alzheimer's Research and Therapy, Pediatric Neurology, the Journal of Ultrasound in Medicine, Muscle & Nerve, and Epilepsia. She also has also been invited to write book chapters on Alzheimer’s disease, normal pressure hydrocephalus, Parkinson’s disease dementia and Lewy body dementia, and the cognitive and psychiatric consequences of neuroimmunological disorders published by Elsevier and McGraw-Hill.
Presentations by Dr. Skylar-Scott have focused on prevention of cognitive decline in at-risk elderly people, cognitive and neuropsychiatric manifestations of Parkinson’s disease, human prion diseases, and other topics. She has presented at meetings held by the American Academy of Neurology (AAN), the American Neurological Association (ANA), and the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM).
For her research and scholarship, Dr. Skylar-Scott has earned honors from the American Academy of Neurology (AAN) and the Howard Hughes Medical Institute (HHMI). She was honored to receive the Golseth Young Investigator Award from the American Association of Neuromuscular & Electrodiagnostic Medicine. In addition, she won the Action Duchenne International Conference First Prize Poster for her research in Duchenne muscular dystrophy.
Dr. Skylar-Scott is a member of the American Neurological Association and American Academy of Neurology. Every year, she walks to raise money for Alzheimer's disease and Lewy body dementia. -
Yuen So, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), Emeritus
Current Research and Scholarly InterestsResearch in the diagnosis, pathophysiology and treatment of peripheral neuropathy, myasthenia gravis, motor neuron diseases including ALS and SMA, nerve injuries and muscle diseases. Application of clinical neurophysiological methods to neurological diagnosis. Development of evidence-based medicine pertaining to the practice of neurology.
-
Kristen K. Steenerson, MD
Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)
Clinical Assistant Professor, Adult NeurologyBio=Dr. Kristen K. Steenerson is a Clinical Associate Professor at Stanford University School of Medicine, specializing in vestibular neurology and neuro-otology. She directs clinical care within the Vestibular Neurology Clinic at the Stanford Ear Institute, where she focuses on the diagnosis and management of complex dizziness and balance disorders, including vestibular migraine, benign paroxysmal positional vertigo, Ménière disease, bilateral vestibulopathy, and persistent postural-perceptual dizziness.
Her academic program integrates translational research with clinician education to improve the diagnosis and treatment of vestibular disorders. Her research focuses on the development and validation of objective, technology-enabled tools to measure vestibular function in real-world settings. She leads initiatives evaluating wearable electro-oculography platforms for ambulatory nystagmus detection, as well as sensor-based systems using inertial measurement units to assess mobility, fall risk, and functional engagement. Her work leverages multidisciplinary collaboration across neurology, otolaryngology, audiology, engineering, and data science, with the goal of establishing scalable digital biomarkers and vestibular-specific clinical trial endpoints.
In parallel, Dr. Steenerson is deeply engaged in national and international clinician education. She serves as course director and faculty for multiple continuing medical education programs in vestibular neurology and neuro-otology, with a focus on bedside examination skills, acute dizziness evaluation, and diagnostic reasoning. She has developed interdisciplinary curricula and clinical training pathways designed to expand vestibular expertise among neurologists, otolaryngologists, advanced practice providers, and trainees.
Her scholarly work also includes clinical outcomes research and care delivery innovation, particularly in vestibular migraine and episodic vertigo disorders. She has led initiatives to standardize triage, referral pathways, and multidisciplinary care models for patients with dizziness, translating evidence into practical frameworks that improve access, diagnostic accuracy, and patient outcomes.
Through the integration of clinical innovation, translational research, and clinician education, Dr. Steenerson’s work aims to modernize vestibular care and expand the reach of specialized expertise beyond tertiary referral centers. -
Chris Tarver, MD, FAAPMR
Clinical Assistant Professor, Orthopaedic Surgery
Clinical Assistant Professor (By courtesy), Neurosurgery
Clinical Assistant Professor (By courtesy), Adult NeurologyBioDr. Tarver is board-certified in Physical Medicine and Rehabilitation and Brain Injury Medicine, with an emphasis on stroke rehabilitation. He is also a clinical assistant professor in the Department of Orthopaedic Surgery and a clinical assistant professor (by courtesy) in the Department of Neurosurgery and the Department of Neurology & Neurological Sciences at Stanford University School of Medicine. Dr. Tarver completed a PM&R residency at Loma Linda University Health. Prior to that, he received his Bachelor of Science in Biomedical Engineering and Doctor of Medicine degrees from Texas A&M University.
-
Ryan Taylor, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.
His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.
Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.
He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.
Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology. -
Kate Therkelsen, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Therkelsen is a board-certified, fellowship-trained neuro-oncologist with the Stanford Medicine Cancer Center and a clinical assistant professor in the Department of Neurology and Neurological Sciences.
She diagnoses and treats a wide range of conditions including primary brain tumors and cancers of the central nervous system, metastatic disease to the brain and spinal cord, and neurologic complications of cancer. She prepares a personalized, comprehensive care plan for each patient she serves.
Dr. Therkelsen’s research interests include clinical trials of new therapeutics, as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. Her fellowship research projects included a study of survival and long-term function among patients treated for primary central nervous system lymphoma. She also received a pre-doctoral National Institutes of Health Intramural Research Training Award for her work with the Framingham Heart Study.
She has published in Current Treatment Options in Oncology and other peer-reviewed journals. She has presented to her peers at international, national, and regional meetings, including the annual meetings of the Society of Neuro-Oncology and of the American Academy of Neurology.
Dr. Therkelsen is a member of the Society of Neuro-Oncology and the American Academy of Neurology.
